TONELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 15.039
AS - Asia 8.591
EU - Europa 7.728
SA - Sud America 1.316
AF - Africa 226
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.981
Nazione #
US - Stati Uniti d'America 14.611
IT - Italia 3.256
SG - Singapore 2.743
CN - Cina 1.983
GB - Regno Unito 1.036
VN - Vietnam 999
BR - Brasile 956
HK - Hong Kong 867
DE - Germania 725
SE - Svezia 627
BD - Bangladesh 539
RU - Federazione Russa 363
FI - Finlandia 337
FR - Francia 330
KR - Corea 252
CA - Canada 246
IN - India 232
ID - Indonesia 216
NL - Olanda 184
AR - Argentina 138
TR - Turchia 138
JP - Giappone 129
UA - Ucraina 125
MX - Messico 122
BG - Bulgaria 87
ES - Italia 85
IE - Irlanda 80
PL - Polonia 73
IQ - Iraq 71
ZA - Sudafrica 67
AU - Australia 65
CO - Colombia 65
PK - Pakistan 63
LT - Lituania 54
AT - Austria 48
RO - Romania 48
AE - Emirati Arabi Uniti 44
EC - Ecuador 42
BE - Belgio 41
CL - Cile 41
CH - Svizzera 32
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
MY - Malesia 28
EG - Egitto 27
VE - Venezuela 26
JO - Giordania 25
TH - Thailandia 25
UZ - Uzbekistan 23
SA - Arabia Saudita 22
DZ - Algeria 21
PH - Filippine 20
SI - Slovenia 20
IR - Iran 19
KE - Kenya 19
PY - Paraguay 19
GR - Grecia 18
NP - Nepal 17
TN - Tunisia 16
PE - Perù 15
AZ - Azerbaigian 14
CR - Costa Rica 14
DK - Danimarca 14
NO - Norvegia 14
HU - Ungheria 13
IL - Israele 13
PT - Portogallo 13
KZ - Kazakistan 11
SN - Senegal 11
DO - Repubblica Dominicana 10
HR - Croazia 9
JM - Giamaica 9
MD - Moldavia 9
OM - Oman 9
RS - Serbia 9
EE - Estonia 8
AL - Albania 7
GE - Georgia 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BH - Bahrain 6
BY - Bielorussia 6
GA - Gabon 6
KG - Kirghizistan 6
LB - Libano 6
PA - Panama 6
BO - Bolivia 5
ET - Etiopia 5
LI - Liechtenstein 5
MK - Macedonia 5
PR - Porto Rico 5
PS - Palestinian Territory 5
QA - Qatar 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LK - Sri Lanka 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 32.916
Città #
Ashburn 1.812
Singapore 1.778
Santa Clara 1.477
Fairfield 1.279
Chandler 840
Hong Kong 840
San Jose 737
Council Bluffs 600
Woodbridge 595
Hefei 580
Houston 512
Seattle 471
Cambridge 407
Southend 399
Beijing 376
Wilmington 371
London 360
New York 353
Nyköping 349
Ho Chi Minh City 322
Milan 309
Ann Arbor 307
Los Angeles 290
Modena 270
Helsinki 242
Seoul 232
Hanoi 225
Chicago 221
San Diego 208
Bologna 188
Jakarta 188
Rome 179
The Dalles 173
Dearborn 160
Munich 158
Dallas 127
Jacksonville 125
Moscow 111
Shanghai 105
Lauterbourg 104
Tokyo 101
São Paulo 96
Buffalo 94
Princeton 94
Sofia 84
Orem 79
Toronto 76
Redwood City 68
Dublin 62
Grafing 62
Salt Lake City 61
Frankfurt am Main 60
Parma 59
Naples 58
Boardman 55
Warsaw 55
Mexico City 53
Chennai 47
Montreal 47
Mumbai 46
Nuremberg 46
Turin 46
Bremen 45
Da Nang 44
Elk Grove Village 44
Eugene 43
Lappeenranta 42
Atlanta 41
Poplar 41
Florence 40
Verona 40
Haiphong 39
North York 37
Sydney 36
Denver 35
Reggio Emilia 34
Hangzhou 33
Johannesburg 33
Phoenix 33
Rio de Janeiro 33
Ankara 32
Brussels 32
Turku 32
Brooklyn 31
Guangzhou 31
Miami 31
Hillsboro 30
Kent 30
Baghdad 29
Izmir 28
Stockholm 28
Tampa 28
Amsterdam 27
Des Moines 27
Redondo Beach 27
Boston 26
Dong Ket 26
Paris 26
Lahore 25
Fremont 24
Totale 21.092
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 515
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 455
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 437
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 425
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 389
Insufficienza respiratoria acuta e cronica (cap.21). 386
Acute severe asthma: management and treatment. 382
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 377
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 375
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 369
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 367
An uncommon cause of hemoptysis: aortobronchial fistula. 363
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 360
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 360
When Acute Respiratory Distress Syndrome is not ARDS 348
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 346
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 345
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 338
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 337
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 337
An uncommon cause of pneumonia: The golden diagnosis 336
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 331
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 325
Hypokalemia in Patients with COVID-19 324
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 323
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 323
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 320
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 319
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 319
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 316
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 311
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 311
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 308
Breakthroughs in internal and respiratory medicine 305
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 304
Peritoneal dialysis in the time of coronavirus disease 2019 303
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 302
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 294
Novel drug targets for idiopathic pulmonary fibrosis 292
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 291
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 291
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 285
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 279
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 278
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 277
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 277
Looking for a Chronic Care Model in COPD patients 272
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 270
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 269
The encaged lung: rapidly progressive idiopathic pleurisy. 268
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 268
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 266
Never Give Up: lesson learned from a severe COVID-19 patient. 265
Atypical diagnosis for typical lung carcinoid 259
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 256
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 254
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 253
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 252
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 250
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 250
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 249
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 249
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 246
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 241
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 240
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 237
Janus-faced amiodarone-induced pneumopathy 235
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 233
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 230
Response Letter to Tuffet S, et al. and to Michard F, et al. 228
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 226
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 226
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 226
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 221
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 221
Impaired function in the complex patient with COPD: a matter to be considered 220
An Italian sacrifice to COVID-19 epidemic. 220
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 217
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 213
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 213
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 212
Unusual effectiveness of systemic steroids in Whipple disease. 209
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 208
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 207
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 205
Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia 205
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy 203
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 203
Extensive tracheal injuries: a reasoned multi-step approach to guarantee mechanical ventilatory support developed during COVID-19 pandemic. 200
Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula 199
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 199
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 199
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 198
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 197
Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study 196
Quantitative CT-analysis of over aerated lung tissue and correlation with fibrosis extent in patients with idiopathic pulmonary fibrosis. 190
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 189
Totale 28.006
Categoria #
all - tutte 133.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 0 0 0 0 0 0 211
2021/20222.942 279 167 152 122 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202613.525 971 566 999 1.576 1.848 778 1.561 683 1.269 1.331 1.170 773
Totale 33.329